BOOM Summit set to revolutionize the healthcare landscape
DayOne – the Basel-based healthcare innovation initiative – and Kenes Group are thrilled to announce the inau-gural BOOM Summit, a truly fresh take on the healthcare conferencing experience launching in April 2024. This highly anticipated healthtech event will act as a nexus between the healthcare, tech, government, and research sectors, providing an open forum for everyone – from professionals and entrepreneurs to investors and policy-makers – to discuss the latest trends, technologies, and strategies poised to transform healthcare.
The summit will provide valuable access to key thought leaders from across the entire healthtech ecosystem via a host of expert panels, technology showcases, startup pitch sessions, interactive workshops, networking opportunities, and more. It will present unique opportunities to exchange knowledge, interact with potential investors, stay up to date with industry trends and regulations, discover innovative digital solutions, and contribute to the collective effort of reshaping healthcare on a global scale.
BOOM Summit 2024 is set to be a highlight of the European healthtech calendar, with speakers from various industries already signed up and expressing their excitement for the event. Dr Michelangelo Canzoneri, Global Head of Smart Manufacturing at Merck, explained why he is eager to attend: “When I heard about BOOM Summit’s mission to revolutionize the healthtech landscape, I knew I had to be a part of it; the opportunity to share and learn from peers and collaborate with like-minded professionals was too good to pass up.” Another speaker looking forward to the event is Chandana Fitzgerald, MD and CEO of HealthXL, stating: “BOOM Summit is really pushing the envelope in the European healthtech events space, bringing together bright minds from Basel and beyond to help them experience their own ‘eureka’ moments and return home with a vastly expanded network.»
The future of healthcare is poised for a seismic shift, and BOOM Summit is leading the charge. This game-changing event will take place April 10-11, 2024, at Messe Basel*, a state-of-the-art exhibition and convention facility in the heart of Europe’s leading life sciences hub. Secure your spot at BOOM Summit now to position yourself at the forefront of the healthtech revolution.
* Venue provided by BOOM Summit’s key partner MCH Group
DayOne is the healthcare innovation initiative in the Basel area. With a platform for collaborative innovation across disciplines and industries, it accelerates startups, launches catalyst projects, and hosts a community and events to bring innovative healthcare ventures forward. Since 2018, DayOne has supported 23 companies with a combined valuation of over CHF 80 million, contributing to the life sciences ecosystem of the Basel area. DayOne is run by Basel Area Business & Innovation – the investment and promotion agency for the Basel area – and is significantly financed by the cantons of Basel-Stadt and Jura.
About Kenes Group
Over the past five decades, Kenes Group has established and maintained its winning reputation as a global meeting and association management provider. Recognized as the world leader in meeting planning, the company is the only global PCO dedicated to medical and scientific events. Kenes Group boasts a long-standing client base of some of the world’s foremost organisations and associations, with more than 100 returning and long-term clients.
About MCH Group
MCH Group, with its headquarters in Basel, is an internationally active experience marketing company with an extensive network of services. It organizes around 30 community platforms in Switzerland and abroad, including Art Basel, Swissbau and Giardina. The Live Marketing Solutions division, with the MCH Global, MC2 and Expomobilia brands, offers comprehensive experience marketing solutions ranging from strategy and creation to implementation. The MCH Group also operates Messe Basel, the Congress Center Basel and Messe Zürich. The company employs over 800 people, around half of them in Switzerland and the USA. In the 2022 financial year, the group generated consolidated sales of CHF 394 million.